Clinical Trial Detail

NCT ID NCT00569296
Title Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roger Williams Medical Center
Indications

lung non-small cell carcinoma

Therapies

Aldesleukin + EGFRBi-armed autologous activated T cells + Sargramostim

Age Groups: adult senior

No variant requirements are available.